5G will be leveraged to realise new opportunities for regional businesses, academic researchers, University staff and students. Warwick is the first University campus that has proactively been given 5G activation by BT.
Learn how this can change our lives.
Hear from expert speakers:
Wendy Coy – Director of Operations, Innovation Group, and Facilitator
David Plumb – Chief Innovation Officer, Innovation Group, University of Warwick
Lucy Baker – Service Technology Director, CTIO, BT Enterprise
Darren Farmer – Business Development Director, BT
Professor Theodoros N. Arvanitis holds the Chair of Digital Health Innovation and he is the Director of The Institute of Digital Healthcare, WMG, at University of Warwick.
Dr Leandro Pecchia – Associate Professor (reader) of Biomedical Engineering. Director of the Applied Biomedical Signal Processing and Intelligent eHealth Lab
Robert Franks – Managing Director of West Midlands 5G Limited
ARCHIPELAGO 2035 - Artificial Intelligence, ICT and Assistive Technology: Application In the life of people with disabilities
Silvio Pagliara held the webinar: How technology and AI can improve the quality of life. Archipelago 2035 – Russian Federation, Multiple Universities
The speech was an overview on the design of the Assistive technology and how the Artificial Intelligence is changing them towards a true empowerment of people with disabilities in everyday life.
(in Russian - use the browser automatic translation tool)
ODIN: we have been awarded a new H2020 research project for transforming the future of health care delivery in Hospitals using robots, IoT and AI
Demographic changes push the NHS to contain costs, while keeping healthcare safe and effective. Hospitals remain a critical node of the NHS accounting for the majority of helathcare costs.
We are part of a European team that has been awarded a new Horizon 2020 project, for changing clinical and logistic procedures in hospitals using Artificial Intelligence, Internet of Things and robots.
Read more details here
The European Union will build an Agency for Biomedical Advanced Research and Development - BARDA
Yesterday, 16th of September 2020, the President of the European Commission von der Leyen announched the "we need to strengthen our crisis preparedness and management of cross-border health threats."
She also announced a very clear plan:
As a first step, we will propose to reinforce and empowerthe European Medicines Agencyand ECDC – our centre for disease prevention and control.
As a second step, we will build a European BARDA – an agency for biomedical advanced research and development. This new agency will support our capacity and readiness to respond to cross-border threats and emergencies – whether of natural or deliberate origin. We need strategic stockpiling to address supply chain dependencies, notably for pharmaceutical products.
As a third step, it is clearer than ever that we must discuss the question of health competences. And I think this is a noble and urgent task for the Conference on the Future of Europe. And because this was a global crisis we need to learn the global lessons. This is why, along with Prime Minister Conte and the Italian G20 Presidency, I will convene a Global Health Summit next year in Italy. This will show Europeans that our Union is there to protect all."
This launch of the BARDA is a great news, which will position Europe at the first place for the biomedical engineering research and innovation.
The Applied Biomedical Signal Processing Intelligent eHealth (ABSPIE) Lab has been deeply dealing with COVID-19 since the first few cases in the UK.
Led by Dr Pecchia, the ABSPIE Lab multidisciplinary Team has been involved in several activities, briefly described below, giving a significant contribution to tackle the COVID-19 pandemic.